Literature DB >> 3201693

First field trial of fox vaccination against rabies using a vaccinia-rabies recombinant virus.

P P Pastoret1, B Brochier, B Languet, I Thomas, A Paquot, B Bauduin, M P Kieny, J P Lecocq, J De Bruyn, F Costy.   

Abstract

A field trial of fox vaccination against rabies using a vaccinia-rabies recombinant virus was carried out in Belgium on October 24, 1987. Each vaccine capsule contained a suspension of 10(8) TCID50 of the recombinant virus and was introduced into a chicken head. Each chicken head contained 150 mg of tetracycline as a marker of uptake. Two hundred and fifty heads were distributed in an area of 6 km2 situated within a military zone. The bait uptake was monitored for 15 days after the distribution. Sixty-three per cent of the chicken heads were taken by wild animals within that period. The trial was controlled according to the rules defined by the World Health Organisation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3201693     DOI: 10.1136/vr.123.19.481

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  11 in total

1.  Vaccinia viruses with a serpin gene deletion and expressing IFN-gamma induce potent immune responses without detectable replication in vivo.

Authors:  Fatema A Legrand; Paulo H Verardi; Kenneth S Chan; Yue Peng; Leslie A Jones; Tilahun D Yilma
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-10       Impact factor: 11.205

2.  From vaccines to global health to vaccines.

Authors:  Marie-Paule Kieny
Journal:  Hum Vaccin Immunother       Date:  2018-09-14       Impact factor: 3.452

3.  Reservoir targeted vaccine for lyme borreliosis induces a yearlong, neutralizing antibody response to OspA in white-footed mice.

Authors:  Luciana Meirelles Richer; Miguel Aroso; Tania Contente-Cuomo; Larisa Ivanova; Maria Gomes-Solecki
Journal:  Clin Vaccine Immunol       Date:  2011-09-14

4.  Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine.

Authors:  K M Charlton; M Artois; L Prevec; J B Campbell; G A Casey; A I Wandeler; J Armstrong
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

5.  The development and use of a vaccinia-rabies recombinant oral vaccine for the control of wildlife rabies; a link between Jenner and Pasteur.

Authors:  P P Pastoret; B Brochier
Journal:  Epidemiol Infect       Date:  1996-06       Impact factor: 2.451

Review 6.  Oral vaccination of wildlife using a vaccinia-rabies-glycoprotein recombinant virus vaccine (RABORAL V-RG®): a global review.

Authors:  Joanne Maki; Anne-Laure Guiot; Michel Aubert; Bernard Brochier; Florence Cliquet; Cathleen A Hanlon; Roni King; Ernest H Oertli; Charles E Rupprecht; Caroline Schumacher; Dennis Slate; Boris Yakobson; Anne Wohlers; Emily W Lankau
Journal:  Vet Res       Date:  2017-09-22       Impact factor: 3.683

Review 7.  New human rabies vaccines in the pipeline.

Authors:  Anthony R Fooks; Ashley C Banyard; Hildegund C J Ertl
Journal:  Vaccine       Date:  2018-08-25       Impact factor: 3.641

Review 8.  Adenoviruses as vectors for delivering vaccines to mucosal surfaces.

Authors:  L A Babiuk; S K Tikoo
Journal:  J Biotechnol       Date:  2000-09-29       Impact factor: 3.307

Review 9.  Blocking pathogen transmission at the source: reservoir targeted OspA-based vaccines against Borrelia burgdorferi.

Authors:  Maria Gomes-Solecki
Journal:  Front Cell Infect Microbiol       Date:  2014-09-26       Impact factor: 5.293

10.  Veterinary vaccines.

Authors:  L A Babiuk; A A Potter
Journal:  Biotechnol Adv       Date:  1994       Impact factor: 14.227

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.